High Photocytotoxicity Iridium(III) Complex Photosensitizer for Photodynamic Therapy Induces Antitumor Effect Through GPX4‐Dependent Ferroptosis
Small · 2025
DOI: 10.1002/smll.202403165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Qing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing, 211816, China. Hauptthemen laut MEDLINE: Ferroptosis, Photochemotherapy, Iridium, Photosensitizing Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Postgraduate Research & Practice Innovation Program of Jiangsu Province, Nanjing Life Health Science and Technology Special Project.
Abstract (Originalsprache)
The development of small molecule photosensitizers based on iridium complex is limited by the mismatch between therapeutic effect and systemic toxicity, as well as the incomplete understanding of the molecular mechanism underlying cell death induction. Herein, a small molecule iridium complex IrC with high photocytotoxicity is synthesized, with half maximal inhibitory concentration as low as 91 n m , demonstrating excellent anti‐tumor, relief of splenomegaly, and negligible side effects. Starting from the factors of effective photosensitizers, the in‐depth theoretical analysis on photon absorption efficiency, energy transfer level matching, and properties of the triplet excited state of IrC is conducted. This also elucidates the feasibility of generating the high singlet oxygen quantum yield. In addition, the death mechanism induced by IrC is focused, innovatively utilizing GPX4‐overexpression and GPX4‐knockout cells via CRISPR/Cas9 technique to comprehensively verify ferroptosis and its further molecular mechanism. The generation of ROS mediated by IrC, along with the direct inhibition of GPX4 and glutathione, synergistically increased cellular oxidative stress and the level of lipid peroxidation. This study provides an effective approach for small molecule complexes to induce GPX4‐dependent ferroptosis at low‐dose photodynamic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing, 211816, China.
- School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816, China.
ORCID-Profile: Rui Liu
Förderung
- National Key Research and Development Program of China
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Nanjing Life Health Science and Technology Special Project
- National Basic Research Program of China
Zitieren
APA
Zhang, Q., Chen, D., Liu, X., Deng, Z., Li, J., Zhu, S., Ma, B., Liu, R., & Zhu, H. (2025). High Photocytotoxicity Iridium(III) Complex Photosensitizer for Photodynamic Therapy Induces Antitumor Effect Through GPX4‐Dependent Ferroptosis. Small. https://doi.org/10.1002/smll.202403165
Vancouver
Zhang Q, Chen D, Liu X, Deng Z, Li J, Zhu S, et al. High Photocytotoxicity Iridium(III) Complex Photosensitizer for Photodynamic Therapy Induces Antitumor Effect Through GPX4‐Dependent Ferroptosis. Small. 2025. doi:10.1002/smll.202403165
BibTeX
@article{Zhang2025,
author = {Zhang, Qing and Chen, Dezhi and Liu, Xiaomeng and Deng, Zhewen and Li, Jiaqi and Zhu, Senqiang and Ma, Bo and Liu, Rui and Zhu, Hongjun},
title = {High Photocytotoxicity Iridium(III) Complex Photosensitizer for Photodynamic Therapy Induces Antitumor Effect Through GPX4‐Dependent Ferroptosis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202403165}
}
EUVIMED